CHAPTER 1 - MARKET SUMMARY
Market Overview
The India Medical Devices Market operates through a mix of imported high-value systems, domestic consumables, implants, diagnostics and increasingly connected devices sold to hospitals, laboratories, clinics and home-care users. Demand is structurally underpinned by 9.84 crore authorized hospital admissions under AB-PMJAY by July 2025, creating a large procedure-linked purchasing base for imaging, monitoring, surgical and diagnostic equipment.
Supply and demand are concentrated in South and West India, where Bengaluru, Chennai, Hyderabad, Mumbai, Pune and Gujarat combine manufacturing clusters with large hospital networks. Nationally, 8,18,661 beds were available across public facilities and medical colleges as of March 2023; the persistent bed-density gap makes capacity additions commercially important for equipment vendors and service partners.
Market Value
USD 15,500 million
2025
Dominant Region
South India
2025
Dominant Segment
AI-Enabled Diagnostic Systems
fastest growing, 2026-2031
Total Number of Players
1,200
Future Outlook
The India Medical Devices Market is projected to expand from USD 15,500 Mn in 2025 to USD 34,456 Mn by 2031, representing a forecast CAGR of 14.20%. Growth should accelerate as public procurement, private hospital expansion and chronic-disease management increase equipment utilization. The historical CAGR of 9.60% during 2020-2025 reflected pandemic volatility, supply normalization and rising domestic capacity. Over 2026-2031, higher-value imaging, cardiac intervention, molecular diagnostics, surgical robotics and connected monitoring are expected to raise the value mix faster than unit volumes, while broader reimbursement coverage reduces demand concentration in top-tier urban hospitals.
The forecast assumes continued implementation of the National Medical Devices Policy, PLI-linked capacity commissioning and gradual reduction in import intensity. By December 2025, approved PLI applicants had generated cumulative eligible sales of ?13,624.52 crore, including ?6,425.48 crore of exports, demonstrating early commercial scaling. Manufacturing parks and common testing infrastructure should improve economics for mid-sized firms, while digital health records and remote monitoring expand demand beyond episodic hospital purchases. Margin pools are likely to shift toward software-enabled diagnostics, service contracts, local components and consumables, while commoditized imported equipment faces stronger tender pricing pressure and localization requirements.
14.20%
Forecast CAGR
$34,456 Mn
2030 Projection
Base Year
2025
Historical Period
2020-2025
Forecast Period
2026-2031
Historical CAGR
9.60%
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, localization, margin pools, capex intensity, exit value
Corporates
portfolio mix, tender access, service uptime, procurement economics
Government
import substitution, compliance, affordability, exports, manufacturing resilience
Operators
installed base, utilization, maintenance, consumables, digital integration
Financial institutions
equipment finance, receivables, covenants, demand stability, credit risk
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020-2025)
Historical performance strengthened after the 2020 supply shock, with annual growth rising from 8.00% in 2021 to 11.03% in 2025. The key inflection occurred during 2023-2025 as elective procedures normalized, corporate hospitals resumed capital expenditure and domestic consumables capacity expanded. Value growth exceeded volume growth by roughly 2.3 percentage points in 2025, indicating a mix shift toward higher-specification diagnostics, monitoring systems and implants rather than pure unit expansion. Demand remained concentrated in tertiary hospitals and diagnostic chains, but government-funded admissions widened the addressable base.
Forecast Market Outlook (2026-2031)
Forecast growth is expected to accelerate from 12.50% in 2026 to a peak of 16.00% in 2030 before moderating to 15.00% in 2031. The six-year CAGR of 14.20% reflects local production of imaging systems, higher penetration of molecular and point-of-care diagnostics, and connected-device adoption across home and ambulatory settings. Value growth should remain 3-4 percentage points above volume growth as software, service contracts and clinical workflow integration increase average revenue per installed system. Localization lowers landed costs but expands profit pools in components, validation, maintenance and digital layers.
CHAPTER 5 - Market Data
Market Breakdown
The market is transitioning from import-led capital equipment toward a broader mix of local manufacturing, recurring consumables and digitally connected platforms. For CEOs and investors, the critical variables are localization speed, import exposure and export scalability.
Year | Market Size (USD Mn) | YoY Growth (%) | Domestic Production Share (%) | Import Dependence (%) | Export Value (USD Bn) | Period |
|---|---|---|---|---|---|---|
| 2020 | $9,800 Mn | +- | 18% | 82% | Forecast | |
| 2021 | $10,584 Mn | +8.00% | 19% | 81% | Forecast | |
| 2022 | $11,537 Mn | +9.00% | 21% | 79% | Forecast | |
| 2023 | $12,691 Mn | +10.00% | 23% | 77% | Forecast | |
| 2024 | $13,960 Mn | +10.00% | 26% | 74% | Forecast | |
| 2025 | $15,500 Mn | +11.03% | 30% | 70% | Forecast | |
| 2026 | $17,438 Mn | +12.50% | 32% | 68% | Forecast | |
| 2027 | $19,703 Mn | +12.99% | 35% | 65% | Forecast | |
| 2028 | $22,461 Mn | +14.00% | 38% | 62% | Forecast | |
| 2029 | $25,830 Mn | +15.00% | 40% | 60% | Forecast | |
| 2030 | $29,962 Mn | +16.00% | 43% | 57% | Forecast | |
| 2031 | $34,456 Mn | +15.00% | 45% | 55% | Forecast |
Domestic Production Share
30% (2025, India). A higher local share improves tender responsiveness and reduces foreign-exchange exposure. By December 2025, 24 greenfield projects and 57 products were operational under PLI, including MRI, CT, ultrasound and radiotherapy systems.
Import Dependence
70% (2025, India). High dependence preserves distributor margins but exposes hospitals to currency, freight and service-part risks. Three medical-device parks had allotted land to 194 manufacturers across 298.58 acres by September 2025, creating infrastructure for gradual substitution.
Export Value
USD 4.1 Bn (FY2024-25, India). Export growth validates quality systems and gives domestic firms a scale path beyond price-sensitive local tenders. Medical-device exports rose from USD 2.5 Bn in FY2020-21 and reached customers across 187 countries.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Product Type
Fastest Growing Segment
Technology
Product Type
Care Setting
End User
Disease Area
Distribution Channel
Technology
Geography
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Product Type
Product economics determine pricing, regulatory intensity, service requirements and localization potential. Diagnostic Imaging Systems remain the largest institutional capital pool, while Consumables and Disposables generate more predictable recurring revenue. In Vitro Diagnostics provides a scalable bridge between centralized laboratories and point-of-care channels, and locally manufactured implants increasingly compete on clinician familiarity, supply reliability and total procedure cost.
Technology
Technology is the fastest-growing dimension as hospitals prioritize workflow productivity, remote care and precision. AI-Enabled Diagnostic Systems are expanding from image triage into decision support and equipment optimization, while Connected and IoT-Enabled Devices create recurring monitoring and software revenue. Minimally Invasive and Robotic Systems should capture premium procedure budgets where clinical outcomes, surgeon training and service uptime justify higher acquisition costs.
CHAPTER 7 - Regional Analysis
Regional Analysis
India ranks fourth among the selected Asian medical-device markets by 2025 value, behind China, Japan and South Korea but ahead of Indonesia. Its combination of lower device penetration, faster hospital expansion and localization policy produces the strongest forecast growth profile in the peer set.
Focus Country Ranking
4th
Focus Country Market Size (2025)
USD 15,500 Mn
India CAGR (2026-2031)
14.20%
Focus Country Ranking
4th
Focus Country Market Size (2025)
USD 15,500 Mn
India CAGR (2026-2031)
14.20%
Regional Analysis (Current Year)
Market Position
India is the fourth-largest Asian market in 2025 among the selected peers, with lower installed capacity but a broader emerging-demand base than Indonesia.
Growth Advantage
India's 14.20% forecast CAGR exceeds Japan at 7.0% and China at 5.9%, positioning it as the peer group's principal scale-growth market.
Competitive Strengths
Strengths include USD 4.1 Bn FY2024-25 exports, 24 commissioned PLI projects and a large procedure pool supported by 9.84 crore authorized admissions.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Challenges & Opportunities
Comprehensive analysis of key factors shaping the India Medical Devices Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Insurance-Funded Procedure Expansion
- 31,466 empanelled hospitals (July 2025, India) expand addressable procurement for imaging, implants, monitoring and surgical consumables; vendors with service coverage beyond metros capture recurring procedure-linked demand.
- ?1.40 lakh crore of authorized treatment value (July 2025, India) improves payment visibility for device-intensive specialties, encouraging hospitals to invest in capacity aligned with reimbursable case volumes.
- 14,194 private hospitals (July 2025, India) were empanelled, giving manufacturers a scalable route through corporate and independent providers rather than relying only on fragmented self-pay demand.
Hospital and Diagnostic Capacity Build-Out
- 2 beds per 1,000 people (National Health Policy target) remains above current public availability, sustaining multi-year procurement for monitors, imaging, laboratory systems and critical-care equipment.
- 808 medical colleges in 2025-26, more than double the 2013-14 level, increase teaching-hospital capacity and create standardized demand for simulation, diagnostics and operating-room systems.
- 32,574 AB-PMJAY hospitals (December 2025, India) indicate a progressively formalized provider network where accredited procurement, uptime contracts and digital integration favor scaled suppliers.
Localization and Export Policy
- ?3,420 crore PLI outlay (2020-2027, India) supports four high-value device categories, improving economics for imaging, radiotherapy, cardio-respiratory, renal and implant manufacturing.
- 57 products in production (December 2025, India) demonstrate movement from assembly toward complex devices; component suppliers and testing providers gain from deeper local value chains.
- USD 4.1 Bn exports (FY2024-25, India) create scale beyond domestic tenders, rewarding firms that invest in international certifications, distributor networks and product documentation.
Market Challenges
High Import Dependence in Advanced Systems
- USD 14 Bn sector size (2024, India) still included substantial imported imaging, electronics and implants, exposing hospital capex to exchange-rate and freight volatility.
- Four PLI target segments (2025, India) focus on the most import-dependent categories, indicating that local component depth, precision tooling and supplier qualification remain bottlenecks.
- 298.58 acres across three device parks (September 2025, India) had land allotments, but infrastructure commissioning and supplier clustering must convert acreage into validated production capacity.
Fragmented Procurement and Price Pressure
- 17,272 public and 14,194 private empanelled hospitals (July 2025, India) use different approval cycles and specifications, increasing selling costs and tender-management complexity.
- 1,961 treatment procedures across 27 specialties (March 2025, India) create reimbursement ceilings that can compress device pricing unless vendors demonstrate lower total procedure cost.
- 1,200 manufacturers represented by AiMeD indicate a fragmented supply base where smaller firms face weaker bargaining power, slower receivables and limited national service coverage.
Regulatory and Quality-System Complexity
- Class C and Class D devices face higher regulatory scrutiny, making clinical evidence, quality management and post-market surveillance essential cost centers for implant and life-support portfolios.
- 57 newly localized PLI products (December 2025, India) increase demand for domestic testing capacity, trained regulatory personnel and supplier audits before scaled commercialization.
- 194 manufacturers allotted park land (September 2025, India) will require common sterilization, calibration and testing facilities to avoid duplicated capex and delayed market entry.
Market Opportunities
Local Manufacturing of High-Value Equipment
- ?13,624.52 crore cumulative eligible PLI sales (December 2025, India) validate commercial demand for local MRI, CT, ultrasound, radiotherapy and implant production.
- 27 approved PLI applications including 14 MSMEs (July 2026, India) broaden participation beyond conglomerates, benefiting component suppliers, tooling firms and contract manufacturers.
- ?500 crore SMDI outlay (FY2024-25 to FY2027-28, India) must translate into testing, clinical studies and import-reduction investments for the opportunity to scale.
Connected Diagnostics and Remote Monitoring
- 3.86 lakh registered health facilities (June 2025, India) create an integration base for connected diagnostics, device data exchange and remote monitoring subscriptions.
- 5.95 lakh registered healthcare professionals (June 2025, India) expand the user network for clinician dashboards, AI triage and longitudinal device-generated records.
- 66.8% of deaths linked to NCDs (latest WHO estimate, India) supports continuous monitoring models, but interoperability, reimbursement and evidence standards must improve.
Export-Led Scaling of Consumables and Implants
- 64% export growth from FY2020-21 to FY2024-25 indicates international demand for India-made devices; firms gain by combining cost-efficient production with global regulatory approvals.
- 187 destination countries (FY2024-25, India) diversify demand and enable manufacturers to use domestic scale for faster product-line expansion across consumables, IVD and implants.
- ?6,425.48 crore PLI-linked exports (December 2025, India) show early traction, but sustained growth requires distributor service, local registrations and product-liability readiness.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Competition combines multinational technology leaders, scaled Indian manufacturers and specialist mid-sized firms; entry barriers are highest in regulated implants, imaging, service networks and clinician adoption.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
Meril Life Sciences | - | Vapi, India | 2006 | Cardiovascular, orthopedic, diagnostics and surgical robotics |
Siemens Healthineers | - | Erlangen, Germany | 2017 | Imaging, diagnostics, advanced therapies and radiotherapy |
GE HealthCare India | - | Bengaluru, India | 1990 | Imaging, ultrasound, patient monitoring and diagnostics |
Medtronic India | - | Mumbai, India | 1979 | Cardiac, surgical, diabetes and neurovascular devices |
Poly Medicure | - | New Delhi, India | 1995 | Infusion therapy, renal care, diagnostics and disposables |
Transasia Bio-Medicals | - | Mumbai, India | 1979 | In vitro diagnostics and laboratory automation |
Trivitron Healthcare | - | Chennai, India | 1997 | Diagnostics, imaging, critical care and neonatal devices |
Healthium Medtech | - | Bengaluru, India | 2018 | Surgical consumables, wound closure and urology devices |
Sahajanand Medical Technologies | - | Surat, India | 2001 | Coronary stents, structural heart and minimally invasive devices |
BPL Medical Technologies | - | Bengaluru, India | 2013 | Patient monitoring, cardiology, imaging and home care devices |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Installed Equipment Base Growth
Domestic Manufacturing Share
India Segment Revenue Growth
EBITDA Margin
Analysis Covered
Market Share Analysis:
Compares category leadership across equipment, diagnostics, implants and consumables portfolios
Cross Comparison Matrix:
Benchmarks installed base, localization, growth and operating profitability performance
SWOT Analysis:
Assesses technology depth, channel reach, compliance and supply vulnerabilities
Pricing Strategy Analysis:
Evaluates tender pricing, premium systems, consumables and service contracts
Company Profiles:
Reviews portfolios, manufacturing footprint, positioning, partnerships and strategic priorities
CHAPTER 10 - REPORT TOC
Table of Contents
Phase 1Market Assessment Phase
11
Chapters
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Phase 2Go-To-Market Strategy Phase
15
Chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Mapped CDSCO device classification requirements
- Reviewed hospital procurement and reimbursement
- Analyzed medical-device trade and exports
- Benchmarked manufacturing and testing capacity
Primary Research
- Hospital biomedical engineering heads interviewed
- Medical-device procurement directors consulted
- Diagnostic laboratory operations leaders interviewed
- Manufacturer regulatory affairs heads consulted
Validation and Triangulation
- Validated findings across 312 respondents
- Reconciled supply and demand estimates
- Tested price-volume mix consistency
- Reviewed outliers with industry experts
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
- KSA Artificial Intelligence in Healthcare Market Size, Share & Forecast, By Solution Type, Deployment Model & Application, 2026-2031
- Vietnam Medical Imaging Analytics Market
- Egypt Digital Health Records Market
- Oman Remote Monitoring Solutions Market
- Japan Medical Device Manufacturing Market
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals